  Background: State-of-the art selection methods fail to identify weak but
cumulative effects of features found in many high-dimensional omics datasets.
Nevertheless, these features play an important role in certain diseases.
  Results: We present Netboost, a three-step dimension reduction technique.
First, a boosting-based filter is combined with the topological overlap measure
to identify the essential edges of the network. Second, sparse hierarchical
clustering is applied on the selected edges to identify modules and finally
module information is aggregated by the first principal components. The primary
analysis is than carried out on these summary measures instead of the original
data. We demonstrate the application of the newly developed Netboost in
combination with CoxBoost for survival prediction of DNA methylation and gene
expression data from 180 acute myeloid leukemia (AML) patients and show, based
on cross-validated prediction error curve estimates, its prediction superiority
over variable selection on the full dataset as well as over an alternative
clustering approach. The identified signature related to chromatin modifying
enzymes was replicated in an independent dataset of AML patients in the phase
II AMLSG 12-09 study. In a second application we combine Netboost with Random
Forest classification and improve the disease classification error in
RNA-sequencing data of Huntington's disease mice.
  Conclusion: Netboost improves definition of predictive variables for survival
analysis and classification. It is a freely available Bioconductor R package
for dimension reduction and hypothesis generation in high-dimensional omics
applications.
